Products | July 01, 2009

CXL-1020

CXL-1020

Related Content

Imaging Study Shows Widespread Brain Connection Loss in Schizophrenia
News | PET Imaging
Imaging Study Shows Widespread Brain Connection Loss in Schizophrenia

July 14, 2026 — New research is shedding new light on the biological basis of schizophrenia by directly measuring ...

Time July 15, 2026
arrow
Research Finds MRI Could Predict Kidney Disease Before It Develops
News | Magnetic Resonance Imaging (MRI)
Research Finds MRI Could Predict Kidney Disease Before It Develops

June 9, 2026 — An investigator at the Icahn School of Medicine at Mount Sinai has received international recognition for ...

Time June 15, 2026
arrow
Engineers Develop Wearable Ultrasound Patch That Could Improve Care for High-Risk Pregnancies
News | Ultrasound Imaging
Engineers Develop Wearable Ultrasound Patch That Could Improve Care for High-Risk Pregnancies

May 26, 2026 — A soft, wearable ultrasound patch that can continuously monitor a fetus for hours at a time — and it can ...

Time May 27, 2026
arrow
x-ray, ai,
News | X-Ray
Researchers: FDA-cleared Chest X-ray AI Shows Promise in Missed Lung Cancer Detection  

April 29, 2026 — Results from a new study* presented at the American Roentgen Ray Society’s (ARRS) 2026 annual meeting ...

Time April 29, 2026
arrow
mri, contrast agent, FDA
News | Contrast Agents
GE HealthCare: First Patient Dosed in Trial for Manganese-based MRI Contrast Agent

April 23, 2026 — On April 23, GE HealthCare announced the first patient has been dosed in the international, multi ...

Time April 23, 2026
arrow
New Clinical Data on Portable MRI System’s Enhanced Stroke Detection Capabilities Published
News | Magnetic Resonance Imaging (MRI)
New Clinical Data Available on Portable MRI System’s Enhanced Stroke Detection Capabilities

Jan. 27, 2026 — Hyperfine has announced results from the largest data set to date evaluating stroke detection with its ...

Time January 28, 2026
arrow
Nuclidium Receives Patent for Radiodiagnostic Program for PSMA-positive Prostate Cancer
News | PET Imaging
Nuclidium Receives Patent for Radiodiagnostic Program for PSMA-positive Prostate Cancer

Jan. 26, 2026 — Nuclidium, a clinical-stage radiopharmaceutical company developing a proprietary copper-based ...

Time January 27, 2026
arrow
Study Shows High Diagnostic Value, Superior Patient Experience for Portable MRI System
News | Magnetic Resonance Imaging (MRI)
Study Shows High Diagnostic Value, Superior Patient Experience for Portable MRI System

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Focused Ultrasound Therapy
Researchers Develop New Technique that Uses Ultrasound to Activate Drugs Targeting Pancreatic Cancer

Aug. 26, 2025 — In a quest for ever-more-effective treatments for pancreatic cancer, HonorHealth Research Institute is ...

Time August 29, 2025
arrow
Immunis, Inc. has announced that a partnership with Springbok Analytics to implement their MRI-based AI muscle analysis technology in its Phase 1/2a Clinical Trial, assessing the efficacy of its novel secretome therapeutic (IMMUNA) in targeting sarcopenia.
News | Radiology Business
Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now